NZ232575A - Enhancing the efficiency of a fish vaccine and stimulating the immune system using beta-1,3-glucan - Google Patents
Enhancing the efficiency of a fish vaccine and stimulating the immune system using beta-1,3-glucanInfo
- Publication number
- NZ232575A NZ232575A NZ232575A NZ23257590A NZ232575A NZ 232575 A NZ232575 A NZ 232575A NZ 232575 A NZ232575 A NZ 232575A NZ 23257590 A NZ23257590 A NZ 23257590A NZ 232575 A NZ232575 A NZ 232575A
- Authority
- NZ
- New Zealand
- Prior art keywords
- fish
- glucan
- composition
- vaccine
- spg
- Prior art date
Links
- 241000251468 Actinopterygii Species 0.000 title claims description 45
- 229960005486 vaccine Drugs 0.000 title claims description 28
- 210000000987 immune system Anatomy 0.000 title claims description 8
- 230000004936 stimulating effect Effects 0.000 title description 3
- 230000002708 enhancing effect Effects 0.000 title description 2
- 229920002498 Beta-glucan Polymers 0.000 title 1
- 238000000034 method Methods 0.000 claims description 24
- 229920001503 Glucan Polymers 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 18
- 229920002305 Schizophyllan Polymers 0.000 claims description 12
- 239000000427 antigen Substances 0.000 claims description 10
- 102000036639 antigens Human genes 0.000 claims description 10
- 108091007433 antigens Proteins 0.000 claims description 10
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 7
- WDQLRUYAYXDIFW-RWKIJVEZSA-N (2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 WDQLRUYAYXDIFW-RWKIJVEZSA-N 0.000 claims description 6
- FEBUJFMRSBAMES-UHFFFAOYSA-N 2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(OC2C(C(OP)C(O)C(CO)O2)O)C(O)C(OC2C(C(CO)OC(P)C2O)O)O1 FEBUJFMRSBAMES-UHFFFAOYSA-N 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 6
- 241000607525 Aeromonas salmonicida Species 0.000 claims description 5
- 241000894007 species Species 0.000 claims description 4
- 241000277331 Salmonidae Species 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 230000037396 body weight Effects 0.000 claims 1
- 239000007972 injectable composition Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 229920001491 Lentinan Polymers 0.000 description 5
- 229940115286 lentinan Drugs 0.000 description 5
- 238000009360 aquaculture Methods 0.000 description 4
- 244000144974 aquaculture Species 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000007912 intraperitoneal administration Methods 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 208000003512 furunculosis Diseases 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 241001507086 salmonid fish Species 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 241000186812 Renibacterium salmoninarum Species 0.000 description 1
- 241000222481 Schizophyllum commune Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 206010047400 Vibrio infections Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 208000010824 fish disease Diseases 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000020408 systemic-onset juvenile idiopathic arthritis Diseases 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Farming Of Fish And Shellfish (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Fodder In General (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000591568A CA1330303C (en) | 1989-02-20 | 1989-02-20 | Composition and process to enhance the efficacy of a fish vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ232575A true NZ232575A (en) | 1991-03-26 |
Family
ID=4139651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ232575A NZ232575A (en) | 1989-02-20 | 1990-02-16 | Enhancing the efficiency of a fish vaccine and stimulating the immune system using beta-1,3-glucan |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5147862A (is) |
| EP (1) | EP0384323B2 (is) |
| JP (1) | JPH064539B2 (is) |
| CA (1) | CA1330303C (is) |
| DK (1) | DK0384323T4 (is) |
| IE (1) | IE68067B1 (is) |
| IS (1) | IS1860B (is) |
| NZ (1) | NZ232575A (is) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2911554B2 (ja) * | 1990-06-25 | 1999-06-23 | 台糖株式会社 | 抗ウィルス剤 |
| CA2040374C (en) * | 1990-07-06 | 1998-06-16 | Gunnar Rorstad | Process for enhancing the resistance of aquatic animals to disease |
| IE65568B1 (en) * | 1990-10-22 | 1995-11-01 | Unilever Plc | Vaccine compositions for fish |
| JPH0665649B2 (ja) * | 1991-02-01 | 1994-08-24 | 台糖株式会社 | 甲殻類の生体防御能増強剤、感染症予防ワクチン及び飼料 |
| JP3522772B2 (ja) * | 1991-05-21 | 2004-04-26 | 台糖株式会社 | ワクチンの免疫効果増強剤 |
| EP0640348A1 (en) * | 1993-07-26 | 1995-03-01 | Akzo Nobel N.V. | Oil-based and water-based adjuvant mixture |
| NO300692B1 (no) * | 1994-04-29 | 1997-07-07 | Biotec Mackzymal As | Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan |
| GB2308367B (en) * | 1995-12-22 | 1999-10-13 | Scottish Salmon Growers Ass | Aeromonas protein used as a vaccine component |
| US5786343A (en) * | 1997-03-05 | 1998-07-28 | Immudyne, Inc. | Phagocytosis activator compositions and their use |
| DE19911052A1 (de) * | 1999-03-12 | 2000-09-21 | Cognis Deutschland Gmbh | Sonnenschutzmittel |
| DE19911057C2 (de) * | 1999-03-12 | 2001-01-25 | Cognis Deutschland Gmbh | Haarkosmetische Zubereitungen |
| DE19911056B9 (de) * | 1999-03-12 | 2005-09-08 | Biotec Asa | Kosmetische Zubereitungen und deren Verwendung |
| US20020009463A1 (en) * | 2000-02-23 | 2002-01-24 | Jan Raa | Novel, non-antigenic, mucosal adjuvant formulation which enhances the effects of substances, including vaccine antigens, in contact with mucosal body surfaces |
| KR20020094269A (ko) * | 2001-06-08 | 2002-12-18 | 주식회사 더멋진 바이오텍 | 어류의 생장을 촉진시키는 베타글루칸을 포함한 사료 |
| US6939864B1 (en) | 2001-07-09 | 2005-09-06 | Purdue Research Foundation | Animal feed compositions and methods of using the same |
| JP5296531B2 (ja) | 2005-05-05 | 2013-09-25 | センシエント フレイバーズ エルエルシー | βグルカン及びマンナンの製造 |
| US20110129548A1 (en) * | 2006-10-20 | 2011-06-02 | Bioagra, Llc | Immunopotentiating Compositions Comprising Beta-1, 3/1, 6-D-Glucan and Uses Thereof |
| CN106259106A (zh) * | 2016-08-17 | 2017-01-04 | 广西吉品环保科技有限公司 | 一种南方丘陵地带坡地生态养殖草鱼的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3943247A (en) * | 1972-05-22 | 1976-03-09 | Kaken Kagaku Kabushiki Kaisha | Treatment of bacterial infections with glucan compositions |
| JPS5571701A (en) * | 1978-11-24 | 1980-05-30 | Sankyo Co Ltd | Hydrolyzate polysaccharide, its preparation, and immunoregulator containing hydrolyzate polysaccharide as active ingredient |
| JPS56156216A (en) * | 1980-05-06 | 1981-12-02 | Takeda Chem Ind Ltd | Preventing agent and remedy against fish disease |
| JPS5699423A (en) * | 1980-09-10 | 1981-08-10 | Kitasato Inst:The | Immune endowment to cultured fish by vaccine of vibrio disease |
| JPS5995220A (ja) * | 1982-11-22 | 1984-06-01 | Ajinomoto Co Inc | 免疫療法剤 |
| FR2570081B1 (fr) * | 1984-09-10 | 1987-01-09 | Pf Medicament | Polysaccharides membranaires utiles notamment comme medicament et procede pour leur preparation |
-
1989
- 1989-02-20 CA CA000591568A patent/CA1330303C/en not_active Expired - Fee Related
- 1989-02-21 US US07/313,033 patent/US5147862A/en not_active Expired - Lifetime
-
1990
- 1990-02-08 IS IS3545A patent/IS1860B/is unknown
- 1990-02-15 JP JP2034925A patent/JPH064539B2/ja not_active Expired - Fee Related
- 1990-02-16 NZ NZ232575A patent/NZ232575A/en unknown
- 1990-02-16 DK DK90103056T patent/DK0384323T4/da active
- 1990-02-16 EP EP90103056A patent/EP0384323B2/en not_active Expired - Lifetime
- 1990-02-19 IE IE60490A patent/IE68067B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IE68067B1 (en) | 1996-05-15 |
| JPH02256620A (ja) | 1990-10-17 |
| DK0384323T4 (da) | 2001-03-19 |
| DK0384323T3 (da) | 1995-07-17 |
| IS3545A7 (is) | 1990-08-21 |
| US5147862A (en) | 1992-09-15 |
| EP0384323A1 (en) | 1990-08-29 |
| EP0384323B2 (en) | 2001-01-24 |
| EP0384323B1 (en) | 1995-05-03 |
| JPH064539B2 (ja) | 1994-01-19 |
| IS1860B (is) | 2003-04-04 |
| CA1330303C (en) | 1994-06-21 |
| IE900604L (en) | 1990-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5147862A (en) | Composition and process to enhance the efficacy of a fish vaccine | |
| FI104537B (fi) | Menetelmä hiivaglukaanin valmistamiseksi | |
| Soltanian et al. | Beta-glucans as immunostimulant in vertebrates and invertebrates | |
| US5189028A (en) | Composition and method to enhance the efficacy of a fish vaccine and to stimulate the immune system of fish | |
| CN102988981B (zh) | 一种增强爱德华氏菌疫苗免疫接种效果的佐剂及使用方法 | |
| CN1108575A (zh) | 油基和水基佐剂混合物 | |
| US20050020490A1 (en) | A Method of Producing an Economical and Ecologically Sound Natural Immunobiotic Extract for Use as a Health Management Instrument and a Replacement for Growth Promotion Antibiotics in Livestock and Companion Animals. | |
| Farooqi et al. | Immunostimulants for aquaculture health management | |
| Salinas et al. | An assessment of immunostimulants as Mx inducers in Atlantic salmon (Salmo salar L.) parr and the effect of temperature on the kinetics of Mx responses | |
| CN102430120A (zh) | 增强鱼类疫苗免疫接种效果的佐剂及其应用 | |
| CN1245888C (zh) | 抗猪腹泻卵黄抗体饲料添加剂和注射剂及其制备方法 | |
| JPH02218615A (ja) | 水溶性グルカンからなる魚病の予防剤 | |
| US5641761A (en) | Preventive agent against infectious disease of crustacea | |
| EP0295749A1 (en) | Sulpholipopolysaccharides as stimulators of the non-specific defence mechanism | |
| Kumar et al. | Beta Glucan: Avaluable Nutraceuticalfor promoting health in aquaculture (short review) | |
| JPH0723313B2 (ja) | 抗腫瘍剤 | |
| Prathisha | Credit seminar On Immunomodulators in fishes | |
| JP2005060288A (ja) | 免疫賦活剤及び抗腫瘍剤 | |
| Gannam | β‐Glucans | |
| US7438915B2 (en) | Immunopotentiating effect of a Fomitella fraxinea-derived lectin on chicken immunity and resistance to coccidiosis | |
| JP2001342140A (ja) | 魚類・甲殻類用薬剤及び飼料 | |
| JP2001342141A (ja) | 水棲動物・陸棲動物用薬剤及び飼料 | |
| Cook et al. | Glucan enhanced nonspecific and specific immunity against visceral leishmaniasis in C57BL/6 mice | |
| Sasaki et al. | (1→ 3)-β-D-glucan derivatives | |
| Gannam | 𝛃-Glucans |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) |